Comparison of the Clinical Outcome of Carotid Artery Stenting Between Institutions With a Treatment Strategy Based on Risk Factors and Those With First-Line Treatment

Abstract

Purpose:

Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are recommended based on certain risk factors. The volume of an institution’s treatment experience may be associated with good clinical outcomes. There is a dilemma between the treatment strategy based on risk factors and the experience volume. Therefore, we investigated the clinical outcomes of CAS performed at institutions that selected the treatment strategy based on risk factors and those that performed CAS at the first-line treatment.

Materials and Methods:

Patients who underwent CAS at 5 institutions were included in this retrospective case-control study. We defined CEA/CAS institutions as those that selected the treatment option based on risk factors, and CAS-first institutions as those that performed CAS as the first-line treatment. We investigated cases of ischemic stroke, hemorrhagic stroke, myocardial infarction, and deaths within 30 days of the intervention between the CEA/CAS- and CAS-first institution groups. One-to-one propensity score matching was performed to compare rates of ischemic and hemorrhagic strokes within 30 days of the intervention.

Results:

A total of 239 and 302 patients underwent CAS at the CEA/CAS institutions and CAS-first institutions, respectively; ischemic stroke occurred in 12 (5.0%) and 7 patients (2.3%), respectively (p=0.09). No differences in major ischemic strokes (0.8% vs 1.3%; p=0.59), hemorrhagic strokes (0.4% vs 0.3%; p=0.87), or deaths (0.0% vs 0.7%; p=0.21) were observed. Myocardial infarction did not occur in either group. Propensity score analysis showed that ischemic stroke (odds ratio: 1.845, 95% confidence interval: 0.601–5.668, p=0.28) and hemorrhagic stroke (odds ratio: 1.000, 95% confidence interval: 0.0061–16.418, p=1.00) were not significantly associated with either institution group.

Conclusions:

The CAS-specific treatment strategies for CAS can achieve the same level of outcomes as the treatment strategy based on risk factors. The CAS performed based on risk factors in CEA/CAS institutions and the treatment of more than 30 patients/year/institution in CAS-first institutions were associated with good clinical outcomes.

Keywords

carotid artery stenosis carotid artery stenting carotid endarterectomy risk factors volume of treatment experience

Get full access to this article

View all access options for this article.

References

North American Symptomatic Carotid Endarterectomy Trial Collaborators; Barnett

HJM

Taylor

Haynes

, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453.

Yadav

Wholey

Kuntz

, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493–1501.

Brott

Hobson

2nd Howard

, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11–23.

Brott

Halperin

Abbara

, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. Stroke. 2011;42:e420–e463.

Ricotta

Aburahma

Ascher

, et al. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. J Vasc Surg. 2011;54:e1–e31.

Abbott

Paraskevas

Kakkos

, et al. Systematic review of guidelines for the management of asymptomatic and symptomatic carotid stenosis. Stroke. 2015;46(11):3288–3301.

Sakai

Uchida

Iihara

, et al. Japanese surveillance of neuroendovascular therapy in JR-NET—Part II. Japanese registry of neuroendovascular treatment 3. Main report. Neurol Med Chir (Tokyo). 2019;59:106–115.

Cole

Mezher

Catapano

, et al. Nationwide trends in carotid endarterectomy and carotid artery stenting in the post-CREST era. Stroke. 2020;51(2):579–587.

Ikeda

Tsuruta

Nakai

, et al. Anatomical risk factors for ischemic lesions associated with carotid artery stenting. Interv Neuroradiol. 2014;20(6):746–754.

10.

Fanous

Natarajan

Jowdy

, et al. High-risk factors in symptomatic patients undergoing carotid artery stenting with distal protection: Buffalo Risk Assessment Scale (BRASS). Neurosurgery. 2015;77:531–543.

11.

Yoshimura

Yamada

Kawasaki

, et al. Selection of carotid artery stenting or endarterectomy based on magnetic resonance plaque imaging reduced periprocedural adverse events. J Stroke Cerebrovasc Dis. 2013;22:1082–1087.

12.

Sato

Suzuki

Yamada

, et al. Selecting an appropriate surgical treatment instead of carotid artery stenting alone according to the patient’s risk factors contributes to reduced perioperative complications in patients with internal carotid stenosis: a single institutional retrospective analysis. Neurol Med Chir (Tokyo). 2015;55(2):124–132.

13.

Ito

Tsuruta

Nakai

, et al. Treatment strategy based on plaque vulnerability and the treatment risk evaluation for internal carotid artery stenosis. Neurol Med Chir (Tokyo). 2018;58:191–198.

14.

Khandelwal

Chaturvedi

Carotid disease management: surgery, stenting, or medication. Curr Cardiol Rep. 2015;17:625.

15.

Dharmakidari

Bhattacharya

Chaturvedi

Carotid artery stenosis: medical therapy, surgery, and stenting. Curr Neurol Neurosci Rep. 2017;17:77.

16.

Meschia

Klaas

Brown

Jr , et al. Evaluation and management of atherosclerotic carotid stenosis. Mayo Clin Proc. 2017;92(7):1144–1157.

17.

Cowan

Jr Dimick

Thompson

, et al. Surgeon volume as an indicator of outcomes after carotid endarterectomy: an effect independent of specialty practice and hospital volume. J Am Coll Surg. 2002;195(6):814–821.

18.

AbuRahma

Stone

Srivastava

, et al. The effect of surgeon’s specialty and volume on the perioperative outcome of carotid endarterectomy. J Vasc Surg. 2013;58(3):666–672.

19.

Kumamaru

Jalbert

Nguyen

, et al. Surgeon case volume and 30-day mortality after carotid endarterectomy among contemporary Medicare beneficiaries: before and after national coverage determination for carotid artery stenting. Stroke. 2015;46(5):1288–1294.

20.

Sgroi

Darby

Kabutey

, et al. Experience matters more than specialty for carotid stenting outcomes. J Vasc Surg. 2015;61(4):933–938.

21.

AbuRahma

Campbell

Hariri

, et al. Clinical outcome of carotid artery stenting according to provider specialty and volume. Ann Vasc Surg. 2017;44:361–367.

22.

Hussain

Mamdani

, et al. Association between operator specialty and outcomes after carotid artery revascularization. J Vasc Surg. 2018;67(2):478–489.e6.

23.

Sakai

Yoshimura

Taki

, et al. Recent trends in neuroendovascular therapy in Japan: analysis of a nationwide survey—Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2. Neurol Med Chir (Tokyo). 2014;54:1–8.

24.

Hyogo

Taki

Negoro

, et al. Japanese society of neuro-endovascular treatment specialist qualification system. Six years’ experience and introduction of an animal model examination. Interv Neuroradiol. 2008;14:235–240.

25.

Thygesen

Alpert

Jaffe

, et al. Third universal definition of myocardial infarction. Circulation. 2012;126:2020–2035.

26.

Imai

King

, et al. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42:1–28.

27.

Pustejovsky

. clubSandwich: cluster-robust (sandwich) variance estimators with small-sample corrections. R Package Version 0.5.3. 2021. Accessed January 24, 2021. https://CRAN.R-project.org/package=clubSandwich.

28.

Knur

Carotid artery stenting: a systematic review of randomized clinical trials. Vasa. 2009;38:281–291.

29.

Uno

Takai

Yagi

, et al. Surgical technique for carotid endarterectomy: current methods and problems. Neurol Med Chir (Tokyo). 2020;60:419–428.

30.

Yamada

Yoshimura

Kawasaki

, et al. Embolic complications after carotid artery stenting or carotid endarterectomy are associated with tissue characteristics of carotid plaques evaluated by magnetic resonance imaging. Atherosclerosis. 2011;215(2):399–404.

31.

Morr

Lin

Siddiqui

AH.

Carotid artery stenting: current and emerging options. Med Devices (Auckl). 2014;7:343–355.

32.

International Carotid Stenting Study; Ederle

Dobson

Featherstone

, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010;375:985–997.

33.

Murad

Shahrour

Shah

, et al. A systematic review and meta-analysis of randomized trials of carotid endarterectomy vs stenting. J Vasc Surg. 2011;53(3):792–797.

34.

Malas

Leal

Kashyap

, et al. Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system. J Vasc Surg. 2017;65(3):916–920.

35.

Kumins

Kashyap

VS.

Learning curve and proficiency of transcarotid artery revascularization compared to transfemoral carotid artery stenting. Semin Vasc Surg. 2020;33(1–2):16–23.

36.

Yee

Wang

Timsina

, et al. Propensity-matched outcomes of transcarotid artery revascularization versus carotid endarterectomy. J Surg Res. 2020;252:22–29.

37.

Nana

Brotis

Spanos

, et al. A systematic review and meta-analysis of carotid artery stenting using the transcervical approach. Int Angiol. 2020;39:372–380.

38.

Hoshino

Kawai

Sarai

, et al. Noninvasive assessment of stenotic severity and plaque characteristics by coronary CT angiography in patients scheduled for carotid artery revascularization. J Atheroscler Thromb. 2018;25:1022–1031.

39.

Miyachi

Taki

Sakai

, et al. Historical perspective of carotid artery stenting in Japan: analysis of 8,092 cases in The Japanese CAS survey. Acta Neurochir (Wien). 2012;154(12):2127–2137.

40.

Sakai

Yamagami

Matsubara

, et al. Prospective registry of carotid artery stenting in Japan—investigation on device and antiplatelet for carotid artery stenting. J Stroke Cerebrovasc Dis. 2014;23(6):1374–1384.